EUVIMEDEUVIMED entdecken
Crossref

Attenuation of Vascular Dementia Associated Neuroinflammation by Inhibition of the JNK Pathway in HFD / STZ ‐Induced Diabetic Rat Model

Sundas Firdoos iD, Rongji Dai, Fawad Ali Shah, Zahid Younas

Clinical and Experimental Pharmacology and Physiology · 2026-04 · 53 (4)

DOI: 10.1111/1440-1681.70120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, online erschienen am 04.04.2026. Verfasst von Sundas Firdoos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory for Separation and Analysis in Biomedicine and Pharmaceutical, Beijing Institute of Technology (BIT), Beijing, People's Republ…. Hauptthemen laut MEDLINE: Dementia, Vascular, Diet, High-Fat, Diabetes Mellitus, Experimental, Anthracenes. Die Arbeit nennt 64 Literaturangaben. Gefördert von: Beijing Institute of Technology, Riphah International University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes‐associated cognitive impairment represents a major global health burden and is driven by metabolic dysregulation, neuroinflammation, oxidative stress and vascular dysfunction. High‐fat diet (HFD)‐induced metabolic stress is known to exacerbate insulin resistance, cerebrovascular injury while activation of stress‐responsive pathways, including c‐Jun N‐terminal kinase (JNK), thereby contributing to neuroinflammatory and cognitive alterations relevant to vascular cognitive impairment. The present study evaluated the therapeutic potential of JNK inhibition in ameliorating diabetes‐associated cognitive and neuroinflammatory changes using a HFD and streptozotocin (STZ) rat model. Male Sprague Dawley rats were allocated to control (HFD‐fed), disease (HFD + STZ), control+treatment (HFD + SP600125) and treatment (HFD + STZ + SP600125) groups. The treatment groups were administered JNK inhibitor (SP600125) for 2 weeks, and cognitive performance was assessed using the Y‐Maze and Morris water maze tests. Disease rats exhibited significant impairments in learning and memory, accompanied by neuronal damage and elevated neuroinflammatory markers in the hippocampus and cortex. Treatment with the JNK inhibitor SP600125 significantly improved cognitive performance, attenuated neuronal injury and reduced inflammatory signalling. Notably, SP600125 decreased brain levels of NLRP3 and inducible nitric oxide synthase, as measured by enzyme‐linked immunosorbent assay and modulated immunohistochemical markers by increasing TREM‐2 while reducing P53 and TNF‐α levels. Collectively, these results demonstrated JNK activation contributes to diabetes‐associated cognitive and neuroinflammatory alterations and that pharmacological JNK inhibition may mitigate pathological features relevant to vascular cognitive impairment without implying exclusive causality. This study supports JNK signalling as a mechanistically relevant target for addressing cognitive complications associated with diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dementia, VascularDiet, High-FatDiabetes Mellitus, ExperimentalAnthracenesMAP Kinase Signaling SystemNeuroinflammatory DiseasesJNK Mitogen-Activated Protein KinasesAnimalsMaleRats, Sprague-DawleyRatsStreptozocin

Stichwörter der Autor:innen

JNK inhibitionSP600125diabetes mellitusmemory impairmentvascular dementia

Substanzen

StreptozocinAnthracenespyrazolanthroneJNK Mitogen-Activated Protein Kinases

Autor:innen und Institutionen

  • Beijing Key Laboratory for Separation and Analysis in Biomedicine and Pharmaceutical, Beijing Institute of Technology (BIT), Beijing, People's Republic of China.
  • Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University Al-Kharj, Al-Kharj, Saudi Arabia.
  • Department of CS & IT, The University of Azad Jammu & Kashmir, Muzaffarabad, Pakistan.

ORCID-Profile: Sundas Firdoos

Förderung

  • Beijing Institute of Technology
  • Riphah International University

Zitieren

APA

Firdoos, S., Dai, R., Shah, F. A., & Younas, Z. (2026). Attenuation of Vascular Dementia Associated Neuroinflammation by Inhibition of the JNK Pathway in HFD / STZ ‐Induced Diabetic Rat Model. Clinical and Experimental Pharmacology and Physiology, 53(4). https://doi.org/10.1111/1440-1681.70120

Vancouver

Firdoos S, Dai R, Shah FA, Younas Z. Attenuation of Vascular Dementia Associated Neuroinflammation by Inhibition of the JNK Pathway in HFD / STZ ‐Induced Diabetic Rat Model. Clinical and Experimental Pharmacology and Physiology. 2026;53(4). doi:10.1111/1440-1681.70120

BibTeX
@article{Firdoos2026,
  author = {Firdoos, Sundas and Dai, Rongji and Shah, Fawad Ali and Younas, Zahid},
  title = {Attenuation of Vascular Dementia Associated Neuroinflammation by Inhibition of the JNK Pathway in HFD / STZ ‐Induced Diabetic Rat Model},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2026},
  volume = {53},
  number = {4},
  doi = {10.1111/1440-1681.70120}
}
Kostenlos starten →